SARS-CoV-2 M^pro oligomerization as a potential target for therapy

Area of Science:

• Virology
• Biochemistry
• Structural Biology

Background:

• The SARS-CoV-2 main protease (Mpro) is essential for viral replication, making it a key target for antiviral therapies.
• Approved drugs like Paxlovid™ target Mpro, but a deeper understanding of its dimerization is needed for broader applications.
• Mpro's ability to form a functional dimer is crucial, yet the mechanisms and impact on proteolytic activity are not fully elucidated.

Purpose of the Study:

• To investigate the dimerization process of SARS-CoV-2 Mpro using biochemical, structural, and molecular modeling techniques.
• To identify critical residues, such as Arg4 and Arg298, involved in Mpro dimerization.
• To understand how Mpro's oligomerization state influences its enzymatic activity and dimerization propensity.

Main Methods:

• Biochemical assays to assess Mpro activity and dimerization.
• Structural analysis to visualize Mpro conformations.
• Molecular modeling to simulate dimerization dynamics and interactions.

Main Results:

• Changes in Mpro's oligomerization state directly impact its enzymatic activity and dimerization.
• Specific residues, Arg4 and Arg298, were identified as critical for Mpro dimerization.
• A synergistic relationship involving intra- and intermolecular interactions was discovered to influence dimer formation.

Conclusions:

• Mpro dimerization is a critical factor influencing its proteolytic function.
• Targeting Mpro dimerization presents a viable strategy for developing novel antiviral therapeutics.
• The findings support the development of allosteric inhibitors for Mpro, offering new therapeutic avenues against SARS-CoV-2.